Cisatracurium Besylate
NDC 83634-655, cisatracurium besylate, injection, solution, from Avenacy, LLC.
- Product NDC
- 83634-655
- Status
- Listed
- Labeler
- Avenacy, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216539
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83634-655 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CISATRACURIUM BESYLATE10 mg/mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83634-655-20 | 83634065520 | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-655-20) / 20 mL in 1 VIAL, SINGLE-DOSE (83634-655-41) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1c6a8b98-deac-4e25-b4a0-5d0af5090281
Use it
Look up 83634-655 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83634-655 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83634-655. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.